Skip to main content

Jones Erin's Form 4/A amendment

Amended

Gritstone bio, Inc. (GRTS) · filed Dec 3, 2021

Accession no.
0001567619-21-021600
Filed
Dec 3, 2021, 4:43 PM ET
Trade date
Oct 1-4, 2021
Filing delay
63 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Oct 5, 2021

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $21.4K. It was filed 63 days after the trade.

This amendment replaces 0001567619-21-017938 (filed Oct 5, 2021).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones ErinCIK 0001754278Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2021Common StockMOption exerciseAcquired+1,000$0.345+$34546,900Direct
Oct 1, 2021Common StockSSaleDisposed−1,000$10.68−$10,68045,900Direct
Oct 4, 2021Common StockMOption exerciseAcquired+1,000$0.345+$34546,900Direct
Oct 4, 2021Common StockSSaleDisposed−1,000$10.71−$10,71045,900Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 1, 2021Common StockMOption exerciseDisposed−1,000$0.00$034,971Direct
Oct 4, 2021Common StockMOption exerciseDisposed−1,000$0.00$033,971Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.

F2

Includes 25,900 Restricted Stock Units which are subject to vesting.

F3

Fully exercisable.

Remarks

Executive Vice President, Global Regulatory Affairs and Quality

Read the full filing on SEC EDGAR (opens in a new tab)